What we have learned from the systematic treatment enhancement program for bipolar disorder (STEP-BD) study

Psychiatric Annals

Volumn 38, Issue 7, 2008, Pages 450-456

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50649125817     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20080701-02     Document Type: Article

References (37)

1. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003;53(11):1028-1042.
2. Kogan JN, Otto MW, Bauer MS, et al; STEP-BD Investigators. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disord. 2004;6(6):440.449.
3. Ghaemi SN. Hsu DJ. Thase ME. et al. Pharmacologic treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv. 2006;57(5):660-665.
4. Perlis RH, Miyahara S, Marangell LB, et al; STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881.
5. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder Comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Am J Psychiatry. 2004;161(12):2222-2229.
6. Baldassano CF, Marangell LB, Gyulai L, et al. Gender differences in bipolar disorder: retrospective data from the firs 500 STEP-BD participants. Bipolar Disord. 2005;7(5):465.470.
7. Joffe H, Kim DR, Foris JM, et al. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depressed and healthy controls. J Clin Psychiatry. 2006;67(2):297-304.
8. Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in woman with bipolar disorder: preliminary report. J Psychiatr Res. 2008;42(3):247-251.
9. Perlis RH, Delbello MP, Miyahara S, et al. Revisiting depressive-prone bipolar disorder: polarity of initial mood episode and disease course among bipolar I systematic treatment enhancement program for bipolar disorder participants. Biol Psychiatry. 2005;58(7):549-553.
10. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder. Am J Psychiatry. 2006;163(2):217-224.
11. Friedman E, Gyulal L, Bhargava M, et al. Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients. Acta Psychiatr Scand, 2006;113(6):510-517.
12. Waxmonsky JA, Thomas MR, Miklowitz DJ, et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry. 2005;27(5):321-328.
13. Fossey MD, Otto MW, Yates MR, et al; STEP-BD Investigators. Validity of the distinction between primary and secondary substance abuse disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. Am J Addict. 2006;15(2):138-143.
14. Weiss RD. Ostracher MJ, Otto MW, et al. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005;66(6):730-735.
15. Otto MW, Simon NM, Wisniewski SR, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006;189:20-25.
16. Simon MN. Zalta AK, Otto MW, et al. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007;41(3-4):255-264.
17. Simon GE, Hunkeler E, Fireman B, et al. Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord. 2007;9(5):526-530.
18. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147(9):1189-1194.
19. Busch KA, Fawcett J, Jacobs DG. Clinical correlates of inpatient suicide. J Clin Psychiatry. 2003;64(1):14-19.
20. Marangell LB, Bauer MS, Dennehy EB, et al. Prospective predictors of suicide and suicide attempts in 1,566 patients with bipolar disorder followed up to 2 years. Bipolar Disord. 2006;8(5 Pt 2):566-575.
21. Nierenberg AA, Miyahara S, Spencer T, et al; STEP-BD Investigators. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005;57(11):1467-1473.
22. Simon NM, Pollack MH, Fischman D, et al. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005;66(9):1105-1110.
23. Goldberg JF, Allen MH, Miklowitz DA, et al. Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatr Serv. 2005;56(12):1534-1540.
24. Bauer MS, Wisniewski SR, Marangell LB, et al. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2006;67(1):48-55.
25. Marangell LB, Dennehy EB, Wisniewski SR, et al. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry. April 8, 2008: e1-e7.
26. Schneck CD, Miklowitz DJ, Miyahara S, et al. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2008;165(3):370-377.
27. Truman CJ, Goldberg JF, Ghaemi SN, et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry. 2007;68(10):1472-1479.
28. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry. 2007;164(9);1346-1355.
29. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722.
30. Ketter TA, Wang PW, Chandler RA, et al. Adjunctive aripiprozole in treatment resistant bipolar patients. Ann Clin Psychiatry. 2006;18(3):169-172.
31. Nierenberg AA, Ostacher MJ, Calabrese JR, et al, Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163(2):210-216.
32. Ketter TA, Brooks JO, Hoblyn JC, et al. Effectiveness of lamotrigine in bipolar disorder in a clinical setting. J Psychiatr Res. April 16, 2008.
33. Wang PW, Yang YS, Chandler RA, et al. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study. J Psychiatr Res. 2008;42(6):451-457.
34. Morris CD, Miklowitz DJ, Wisniewski SR, et al. Care satisfaction, hope, and life functioning among adults with bipolar disorder: data for the first 1000 participants in the Systematic Treatment Enhancement Program. Compr Psychiatry. 2005;46(2):98-104.
35. Lembke A, Miklowitz DJ, Otto DW, et al. Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. J Psychiatr Pract. 2004;10(2):81-87.
36. Miklowitz DJ, Otto MW, Frank E, et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a nine month randomized clinical trial. Am J Psychiatry, 2007;164(9):1340-1347.
37. Fagiolini A, Kupfer DJ, Masalehdan A, Scott JA, Houck PR, Frank E. Functional impairment in the remission phase of bipolar disorder. Bipolar Disord. 2005;7(3):281-285.